HomeFlotufolastat F 18Flotufolastat F 18 + Steroid Therapy

Does Flotufolastat F 18 Interact with Steroid Therapy?

Flotufolastat F 18 and Steroid Therapy have a unknown drug interaction according to U.S. FDA drug labeling data. ADT can result in changes in uptake of flotufolastat F-18 in prostate cancer. Effect on POSLUMA PET performance not established. The mechanism involves changes in androgen pathway affecting radiotracer uptake. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Unknown
Flotufolastat F 18 Class
Radioactive Diagnostic Agent
Management
Consult your pharmacist
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Flotufolastat F 18 and Steroid Therapy occurs because changes in androgen pathway affecting radiotracer uptake. Clinically, this means adt can result in changes in uptake of flotufolastat f-18 in prostate cancer. effect on posluma pet performance not established.

What To Tell Your Doctor or Pharmacist

If you are taking Flotufolastat F 18 and your doctor is considering prescribing Steroid Therapy (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Never stop or change either medication without first consulting your healthcare provider
💊 Flotufolastat F 18(Posluma)+💊 Steroid Therapy(Monistat Simple Therapy)

Severity & Interaction Details

ℹ️
unknown
Interaction documented — severity unclassified
The FDA label notes an interaction but the severity is not classified in our dataset.
Severity scale
MinorContra
On record
Yes
Drug A class
Radioactive Diagnostic Agent
Drug B class
Source
NLP:flotufolastat f-18

What this means in plain English

ADT can result in changes in uptake of flotufolastat F-18 in prostate cancer. Effect on POSLUMA PET performance not established.

About Flotufolastat F 18 and Steroid Therapy

Flotufolastat F 18 is a Radioactive Diagnostic Agent. Flotufolastat F 18 is also sold under the brand name Posluma. Flotufolastat F 18 is given by intravenous (IV) infusion.

What the FDA label says

"Changes in androgen pathway affecting radiotracer uptake"

📖 Source: NLP:flotufolastat f-18

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Flotufolastat F 18 and Steroid Therapy against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.